ArticleJournal of robotic surgery2025
Microscopic positive surgical margins in robotic thyroidectomy: does robotic approach make a difference?
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Microscopic positive surgical margin (mPSM) is a known risk factor of recurrence in patients with differentiated thyroid cancer. While robotic thyroidectomy has gained acceptance as an alternative to open surgery, its impact on margin status remains unclear. This retrospective cohort study analyzed 2587 cases with differentiated thyroid cancer who underwent thyroid surgery between 2009 and 2023. Of these, 206 underwent robotic and 2381 underwent open thyroidectomy. The mPSM rate was comparable between robotic and open groups (4.4 vs. 3.9%, p = 0.743). Multivariable analysis identified larger tumor size, extrathyroidal extension, and multifocality as independent predictors of mPSM, whereas coexisting Hashimoto thyroiditis was associated with a decreased risk. Robotic approach was not an independent risk factor for mPSM (odds ratio 1.647, 95% CI 0.762-3.560). After propensity-score matching, mPSM rates remained similar (4.4% vs 3.4, p = 0.548). In conclusion, robotic thyroidectomy demonstrated oncologic safety comparable to that of open surgery in terms of microscopic margin involvement.
Indexed as
Identifiers
40884628What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.